Harrow (HROW) Current Leases (2014 - 2026)

Harrow's (HROW) quarterly Current Leases came in at $915000.0 in Q1 2026, up 49.75% year-on-year from $611000.0 in Q1 2025, and up 3.16% quarter-over-quarter from $887000.0 in Q4 2025.

Harrow (HROW) Current Leases (2014 - 2026) Analysis & Trends

Harrow's Current Leases history runs 13 years deep, the most recent figure standing at $915000.0 for Q1 2026.

  • On a quarterly basis, Current Leases rose 49.75% year-over-year to $915000.0 in Q1 2026; TTM through Mar 2026 was $915000.0, a 49.75% increase from a year earlier, with the FY2025 full-year figure at $887000.0, up 78.47% from the prior year.
  • Current Leases climbed to $915000.0 in Q1 2026 per HROW's latest filing, from $887000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $915000.0 in Q1 2026 and bottomed at $445000.0 in Q1 2022.
  • The 5-year median for Current Leases is $764000.0 (2023), against an average of $719000.0.
  • Across the five-year window, Current Leases soared 8937.5% in 2022 and sank 38.34% in 2024, its largest moves.
  • Year by year, Current Leases stood at $723000.0 in 2022, then rose by 11.48% to $806000.0 in 2023, then sank by 38.34% to $497000.0 in 2024, then soared by 78.47% to $887000.0 in 2025, then advanced by 3.16% to $915000.0 in 2026.
  • Per Business Quant, the three latest HROW Current Leases figures stand at $915000.0 (Q1 2026), $887000.0 (Q4 2025), and $859000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn 915,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 915,000.00
Dec 31, 2025 887,000.00
Sep 30, 2025 859,000.00
Jun 30, 2025 782,000.00
Mar 31, 2025 611,000.00
Dec 31, 2024 497,000.00
Sep 30, 2024 507,000.00
Jun 30, 2024 767,000.00
Mar 31, 2024 795,000.00
Dec 31, 2023 806,000.00
Sep 30, 2023 785,000.00
Jun 30, 2023 764,000.00
Mar 31, 2023 744,000.00
Dec 31, 2022 723,000.00
Sep 30, 2022 703,000.00
Jun 30, 2022 633,000.00
Mar 31, 2022 445,000.00
Dec 31, 2021 8,000.00
Sep 30, 2021 388,000.00
Jun 30, 2021 485,000.00